Contents
On the neurology shelf, an acute stroke question gives a sudden focal deficit, such as right arm weakness with aphasia, the time the patient was last known well, a fingerstick glucose and a head CT result, then asks for the next best step. It tests the order of decisions: exclude a mimic and a bleed, decide whether the deficit is disabling, match the time window to thrombolysis or thrombectomy, and keep blood pressure inside the right limits.
The algorithm
Steps 1 to 3 happen in the first minutes. Thrombolysis and the search for a large vessel occlusion then run side by side, not one after the other.
- Set the clock and check glucoseStabilize airway, breathing and circulation, then fix the time last known well; every window counts from it. Check blood glucose before thrombolysis. Treat glucose below 60 mg/dL. If a disabling deficit persists after severe hypo- or hyperglycemia is corrected, thrombolysis is still recommended.
- Image the brain right awayNoncontrast CT or MRI excludes hemorrhage. Blood on the scan ends the thrombolysis pathway. Do not hold thrombolysis for coagulation results unless something suggests they will be abnormal, such as anticoagulant use.
- Decide whether the deficit is disablingA disabling deficit is treated whatever the NIHSS score. A mild nondisabling deficit, such as an isolated sensory syndrome, does not get thrombolysis; it has not beaten dual antiplatelet therapy.
- Within 4.5 hours, give a thrombolyticTenecteplase 0.25 mg/kg (maximum 25 mg) as a single bolus, or alteplase 0.9 mg/kg (maximum 90 mg; 10% as a 1-minute bolus, the rest over 60 minutes). Blood pressure must be below 185/110 mm Hg before it starts. Do not delay it for CTA or perfusion imaging.
- Look for a large vessel occlusionGet urgent vascular imaging (CTA or MRA) within 24 hours of last known well, without waiting for a creatinine. A patient eligible for both treatments gets the thrombolytic and goes for thrombectomy; do not wait to see whether the drug works.
- Apply the thrombectomy criteriaICA or M1 occlusion, NIHSS 6 or more, prestroke mRS 0 to 1: thrombectomy within 6 hours with ASPECTS 3 to 10, and from 6 to 24 hours with ASPECTS 6 or more (ASPECTS 3 to 5 in selected patients under 80 without mass effect). Basilar occlusion with NIHSS 10 or more and PC-ASPECTS 6 or more: thrombectomy within 24 hours. Nondominant M2, distal MCA, ACA and PCA occlusions show no benefit.
- Unknown onset or 4.5 to 9 hours: use advanced imagingUnknown onset, seen within 4.5 hours of noticing symptoms, with a DWI lesion smaller than one-third of the MCA territory and no marked FLAIR change: thrombolysis can be beneficial. Salvageable penumbra on perfusion imaging 4.5 to 9 hours from last known well, or within 9 hours of the midpoint of sleep, makes thrombolysis reasonable.
- Hold the blood pressure limitsAfter thrombolysis, keep it below 180/105 mm Hg for at least 24 hours. No reperfusion and blood pressure below 220/120: starting antihypertensives in the first 48 to 72 hours does not prevent death or dependency. Pushing systolic pressure below 140 mm Hg brings no benefit after thrombolysis and causes harm after successful thrombectomy.
- Start antithrombotics on the right dayNo thrombolysis: aspirin within 48 hours. Minor noncardioembolic stroke (NIHSS 3 or less) or high-risk TIA (ABCD2 4 or more): aspirin plus clopidogrel started within 24 hours for 21 days, then one agent. After thrombolysis: repeat CT or MRI at 24 hours before any antiplatelet or anticoagulant. Then find the cause with an ECG and telemetry, echocardiography, carotid imaging, lipids and HbA1c.
Sources differ on exclusions and anticoagulation timing: older references list fixed cutoffs (platelets under 100,000/mm³, INR above 1.7) and wait 7 to 14 days to anticoagulate atrial fibrillation, while the 2026 AHA/ASA guideline grades many exclusions by level of risk and calls early anticoagulation reasonable in selected milder strokes; this post follows the 2026 guideline.
Clue in the stem, next best step
| Clue in the stem | What it points to | Next best step |
|---|---|---|
| Sudden aphasia and right arm weakness, fingerstick glucose 38 mg/dL | Hypoglycemia, a stroke mimic | Treat the glucose; if a disabling deficit persists, continue the stroke pathway |
| Hyperdense blood in the basal ganglia on noncontrast CT | Intracerebral hemorrhage | No thrombolysis; manage as a hemorrhage |
| Disabling deficit at 2 hours, blood pressure 200/115 mm Hg | Above the thrombolysis limit | Lower it below 185/110 mm Hg, then give the thrombolytic |
| Isolated numbness of one side of the body, NIHSS 1 | Mild nondisabling stroke | No thrombolysis; aspirin plus clopidogrel for 21 days |
| NIHSS 14 at 90 minutes, CTA shows an M1 occlusion | Large vessel occlusion inside the lytic window | Thrombolytic now and thrombectomy, without waiting for a response |
| Woke up with hemiparesis, last seen normal 8 hours ago | Unknown onset | MRI: DWI-FLAIR mismatch supports thrombolysis |
| 10 hours, ICA occlusion, NIHSS 12, ASPECTS 7 | Late-window anterior large vessel occlusion | Thrombectomy (allowed up to 24 hours) |
| Vertigo, dysarthria, then coma; basilar occlusion at 12 hours, NIHSS 22 | Basilar artery occlusion | Thrombectomy within 24 hours |
| New headache, vomiting and a worse exam during the alteplase infusion | Suspected hemorrhage after thrombolysis | Stop the infusion; emergency head CT |
| No reperfusion therapy, day 1 blood pressure 190/100 mm Hg | Permissive hypertension | Do not lower it now |
Where students lose points
- Waiting for the INR or platelet count before thrombolysis when nothing suggests a coagulopathy. Glucose is the test that must come first.
- Giving a thrombolytic because the patient is inside 4.5 hours when the deficit is mild and nondisabling. The better answer is dual antiplatelet therapy.
- Skipping the thrombolytic because thrombectomy is planned, or holding thrombectomy to see whether the thrombolytic works. Eligible patients get both, as fast as possible.
- Choosing an intensive blood pressure target. Systolic pressure below 140 mm Hg is not recommended after thrombolysis and is harmful after successful thrombectomy.
- Starting antithrombotics too early after thrombolysis. Get the 24-hour scan first, and never give IV aspirin with thrombolysis or within 90 minutes after it starts.
- Ordering heparin for an undifferentiated acute stroke. Early anticoagulation does not prevent early neurologic worsening.
Practice question
A 64-year-old woman comes to the emergency department 2 hours after sudden numbness of the right side of her face, right arm and right leg. She has no weakness, speech difficulty or visual loss, and she can walk and use her hands normally. She has hypertension and hyperlipidemia treated with amlodipine and atorvastatin and takes no antithrombotic drugs. Temperature is 36.9 C, blood pressure 164/90 mm Hg and pulse 78/min and regular. Fingerstick glucose is 112 mg/dL. Pinprick and light touch are decreased over the right face, arm and leg; strength, coordination, language and visual fields are normal. The NIHSS score is 1. ECG shows sinus rhythm. Noncontrast CT of the head shows no hemorrhage, and CT angiography shows no large vessel occlusion.
Which of the following is the most appropriate treatment?
- IV tenecteplase 0.25 mg/kg
- Aspirin plus clopidogrel
- IV unfractionated heparin infusion
- Mechanical thrombectomy
- IV antihypertensive therapy to bring systolic pressure below 140 mm Hg
Show the answer
Answer: B. She has a minor, nondisabling ischemic stroke (an isolated sensory syndrome, NIHSS 1) in sinus rhythm and was not given thrombolysis. Aspirin plus clopidogrel started within 24 hours of onset and continued for 21 days, followed by a single antiplatelet drug, lowers the risk of another stroke.
Why the others are wrong. A: thrombolysis for mild nondisabling deficits has not shown benefit over dual antiplatelet therapy and adds bleeding risk. C: early anticoagulation for an undifferentiated ischemic stroke does not prevent early worsening, and she has no atrial fibrillation. D: there is no large vessel occlusion, and her NIHSS is below 6. E: without reperfusion therapy and with pressure below 220/120 mm Hg, early lowering does not prevent death or dependency.
60-second recall
Say each answer out loud before you reveal it, then mark yourself. Retrieval, not rereading, is what makes it stick.
1The one test needed before thrombolysis in most patients
Blood glucose.Did you get it?2Blood pressure before and after thrombolysis
Below 185/110 before; below 180/105 for at least 24 hours after.Did you get it?3Tenecteplase dose
0.25 mg/kg, maximum 25 mg, single bolus.Did you get it?4Anterior thrombectomy criteria
ICA or M1 occlusion, NIHSS 6 or more, prestroke mRS 0 to 1, up to 24 hours.Did you get it?5Dual antiplatelet therapy for minor stroke
NIHSS 3 or less or ABCD2 4 or more, start within 24 hours, 21 days.Did you get it?
Make retrieval a habit on every topic with Learning to Learn Medicine. Module 1 is free; the full bundle (the course plus all 12 Recall Labs) is a one-time $199.
Next: browse every Board Review post, review anticoagulants vs antiplatelets vs thrombolytics (including how to reverse a thrombolytic bleed), present a stroke case with MedRise Viva, or see MedRise for students.
Sources
- Prabhakaran S, et al. 2026 Guideline for the early management of patients with acute ischemic stroke: a guideline from the American Heart Association/American Stroke Association. Stroke, 2026 (PubMed)
- Lui F, Khan Suheb MZ, Patti L. Ischemic stroke. StatPearls, NCBI Bookshelf, updated 2026
- Khaku AS, Tadi P. Cerebrovascular disease. StatPearls, NCBI Bookshelf, 2026 edition
MedRise Board Review is educational content for exam preparation only. It is not medical advice and does not replace current guidelines, your school's materials or clinical judgment.



